Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Neuroendocrine Tumors × lenvatinib × Clear all

Phase

Status

Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Carcinoma, Hepatocellular 25 Parkinson Disease 4, Autosomal Dominant Lewy Body 18 Neoplasms 12 Melanoma 7 Carcinoma, Renal Cell 7 Thyroid Neoplasms 6 Endometrial Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Cholangiocarcinoma 5 Recurrence 4 Carcinoma, Non-Small-Cell Lung 4 Carcinoma 4 Biliary Tract Neoplasms 4 Stomach Neoplasms 3 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Colorectal Neoplasms 3 Triple Negative Breast Neoplasms 2 Paraganglioma, Extra-Adrenal 2 Osteosarcoma 2 Lymphoma 2 Liver Neoplasms 2 Glioma 2 Carcinoma, Transitional Cell 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid cancer, Hurthle cell 1 Thyroid Carcinoma, Anaplastic 1 Thyroid Cancer, Papillary 1 Solid Tumors 1

Interventions

Everolimus 14 Octreotide 7 lutetium Lu 177 dotatate 6 pasireotide 5 lanreotide 5 Temozolomide 5 Positron Emission Tomography Computed Tomography 5 surufatinib 4 gallium Ga 68 dotatate 4 Sunitinib 4 Data Collection 4 3-Iodobenzylguanidine 4 Etoposide 3 Carboplatin 3 Capecitabine 3 90Y-octreotide, DOTA-Tyr(3)- 3 pentetreotide 2 pembrolizumab 2 pazopanib 2 fosbretabulin 2 fluorodopa F 18 2 avelumab 2 arginyllysine 2 Sorafenib 2 Single Photon Emission Computed Tomography Computed Tomography 2 Positron-Emission Tomography 2 Pemetrexed 2 PM 01183 2 Magnetic Resonance Spectroscopy 2 Irinotecan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02678780 2025-07-24

TALENT

Grupo Espanol de Tumores Neuroendocrinos

Phase 2 Completed

123 enrolled 37 charts

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡